| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7800796 | European Journal of Medicinal Chemistry | 2014 | 30 Pages |
Abstract
New diacylhydrazine derivatives have been designed and evaluated for their PLK1 inhibitory activity and anti-cervical cancer cell activity. The most active compound is 7k.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Juan Sun, Peng-Cheng Lv, Feng-Jiao Guo, Xin-Yi Wang, Xiao- Han, Yang Zhang, Gui-Hua Sheng, Shao-Song Qian, Hai-Liang Zhu,